Skip to product information
1 of 1

Elabscience

SKU:PKSV030193

Recombinant HIV-1 p24 Protein (group M, subtype C, strain 92BR025) (His Tag)

Recombinant HIV-1 p24 Protein (group M, subtype C, strain 92BR025) (His Tag)

Regular price $855.00 USD
Regular price Sale price $855.00 USD
Sale Sold out
Shipping calculated at checkout.
Size
Introducing the Recombinant HIV-1 p24 Protein (Group M, Subtype C, Strain 92BR025) with a His Tag. This meticulously engineered product offers a highly purified and bioactive protein, specifically designed to cater to the needs of researchers and scientists in the field of HIV-1 research.

Derived from Group M, Subtype C, Strain 92BR025, this recombinant protein exhibits exceptional stability and reliability, ensuring accurate and reproducible results in various experimental settings. The inclusion of a His Tag further facilitates purification and detection processes, enhancing the overall efficiency and convenience of laboratory workflows.

Crafted with utmost precision and adhering to stringent quality control measures, this recombinant HIV-1 p24 Protein guarantees exceptional purity, minimizing the risk of unwanted contaminants that may compromise experimental outcomes. Its bioactivity is meticulously preserved, enabling researchers to delve into the intricate mechanisms of HIV-1 infection and develop novel therapeutic interventions.

This product is meticulously packaged and delivered with utmost care, ensuring its integrity and functionality upon arrival. With its comprehensive documentation, including detailed instructions for use, storage conditions, and handling guidelines, users can confidently incorporate this recombinant protein into their research endeavors.

In summary, the Recombinant HIV-1 p24 Protein (Group M, Subtype C, Strain 92BR025) with a His Tag is a cutting-edge tool that empowers researchers and scientists in their pursuit of unraveling the complexities of HIV-1. Its exceptional purity, stability, and bioactivity make it an indispensable asset in the quest for advancements in HIV-1 research and therapeutic development.
View full details